A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer

Summary

This is a phase 1 study to evaluate safety and tolerability of Telomelysin (OBP-301) in combination with radiation therapy in patient with esophageal cancer who are not applicable to standard therapy.

Timeline

Start

2017-07-07

Primary completion

2019-03

Completion

2019-06

Drugs

Indications